In a novel approach to clinical development that is founded on a shared commitment to cost-disciplined science, Merck and Quintiles have signed a collaboration intended to optimize productivity in the design and execution of studies with a focus on quality, speed, and efficiency.
Olympus Biotech, an Olympus Corporation company, announced its contract manufacturing offering...
GNS Healthcare Inc. has entered into a collaboration with Covance. The collaboration is focused...
Biogen Idec, Forest Laboratories, and Bayer claimed the top three spots in the 2013 Global Investigative Site Relationship survey. More than 2,000 global investigative sites rated the best biopharmaceutical companies to work for across 36 relationship attributes.
TTikoMed AB and Baylor Research Institute (BRI), the research arm of Baylor Health Care System, announced that an agreement has been established to investigate TikoMed's product IBsolvMIR in a Phase 2 clinical trial for the improvement of engraftment of auto islet cell transplantation (AICT), in patients with severe chronic pancreatitis...
Agilent Technologies Inc. and SRI International announced they have signed a licensing agreement to offer laboratory research customers a package that combines Agilent’s latest release of GeneSpring GX, GeneSpring NGS, Mass Profiler Professional and Pathway Architect version 12.5 with SRI International’s complete BioCyc Pathway Database Collection.
SNBL USA Ltd., a subsidiary of Shin Nippon Biomedical Laboratories, has received a formal close out letter from the U.S. Food and Drug Administration (FDA) indicating that it has successfully resolved all the issues identified in an August 10, 2010 warning letter.
TauRx Therapeutics has signed agreements with BioClinica to use Trident IWR/IVR and Imaging Core Lab solutions to support its upcoming Phase 3 clinical trials. TauRx focuses its research on therapies and diagnostics for the treatment of Alzheimer's disease and other neurodegenerative disorders.
PPD has signed an agreement to use Tessella and Berry Consultants' FACTS software to create a more flexible, intuitive approach for trial design. The software expands PPD's adaptive design capabilities by giving biopharmaceutical companies greater ability to use simulations to investigate study design options.
Plexpress has announced plans to extend its collaboration with Admescope. The Tracpack induction screening service is optimized for screening high priority drug candidates, producing all the data required to meet Food and Drug Administration regulations.
Charles River Laboratories International Inc. announced that it has been selected by AstraZeneca as its preferred strategic partner for outsourced regulated safety assessment and development drug metabolism and pharmacokinetics. The three-year agreement extends into 2015.
SNBL USA has received full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) for its animal programs at both SNBL USA in Everett, Wash. and SNBL USA Scientific Resource Center in Alice, Texas.
Advanced Clinical, a provider of clinical research solutions, announced that Susan Paulson, PhD, has been hired as executive director, clinical pharmacology and nonclinical development. Previously, she ran her own consultancy and worked in pharmacology leadership positions at Abbott, NeoPharm, and Searle.
BioClinica Inc. has expanded its imaging services for clinical trials in the area of osteoarthritis (OA), a disease affecting over 21 million people in the United States. developing a device to correctly position patients to measure small changes on film rediographs.
Bend Research Inc., an independent scientific development and manufacturing company, will participate in technical presentations and the exhibition at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, Oct. 14-18 in Chicago.
ChanTest has added a 50,000 compound chemical library from Enamine Ltd. The 3D Diversity Set will be available to ChanTest clients effective immediately for drug discovery services.
Kinexum and Pennington Biomedical Research Center are establishing an integrated approach for emerging companies and early stage therapies to achieve high value regulatory and early phase human clinical trials. The approach will focus on translational research of scientific discoveries and therapeutic developments.
The extent to which genetics contribute to the development of addiction to opioid pain medication is the subject of a new investigation, funded by the National Institutes of Health (NIH). CRI Lifetree is among the facilities awarded the NIH research grant.
AstraZeneca PLC's MedImmune unit is joining with a Chinese pharmaceutical outsourcing company to develop an experimental treatment for autoimmune and inflammatory diseases, deepening the British drug developer's presence in the world's second-largest economy.
Galapagos NV announced that its service division BioFocus and Ono Pharmaceutical Co. Ltd. of Osaka, Japan have signed a new collaboration agreement, focused on discovering novel drugs in the field of CNS disorders. Financial details were undisclosed.
MedPharm, experts in topical drug delivery systems, and Molecular Profiles, a specialist contract development and clinical trial manufacturing organization, announced that they have formed a strategic alliance, branded as MPGMP, to provide an enhanced service for the manufacture of topical formulation clinical trial material.
Ark Therapeutics Group plc announced that it has signed a non-binding letter of intent with EMD Millipore Corporation to enter into a collaborative agreement in the field of viral-based bioengineered vaccines and other live viral products manufacturing.
To help biopharmaceutical companies improve drug development productivity and deliver greater value, Quintiles announced the acquisition of Expression Analysis Inc., a provider of genomics testing and analysis to biopharma, academic, government and non-profit customers.
Molecular Profiles has entered into an alliance with Onyx Scientific to deliver services from initial drug discovery through to early and late phase manufacturing.
Metabolon Inc. has completed its acquisition of Lipomics Technologies Inc. and its TrueMass Profiling lipids technology platform.
BioFocus and Activiomics announced a strategic alliance which will allow BioFocus to offer Activiomics’ proteomics services to its customers.
Clinipace Worldwide, a global digital research organization (dCRO), announced Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has awarded the company an Oncology Program. Immediate plans are commencing for two metastatic melanoma studies.